Physician profile
Steven M Dellose
NPI 1679512685
$51,762.25
in general payments reported to CMS, 2019-2025
22 companies · $19K in 2025
The $19K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,517 · 2020: $2,806 · 2021: $2,635 · 2022: $9,455 · 2023: $11K · 2024: $1,005 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $13K · Consulting Fee: $8,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,000 · Travel and Lodging: $2,710 · Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,112.69 |
| Consulting Fee | $8,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,000.00 |
| Travel and Lodging | $2,709.94 |
| Food and Beverage | $1,025.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $40,695.67 | 2021-2025 | |
| Medical Device Business Services, INC. | $8,121.61 | 2019-2021 | |
| Depuy Synthes Sales INC. | $999.08 | 2019-2024 | Monovisc |
| Stryker Corporation | $521.40 | 2019-2025 | Mako, Insignia |
| Horizon Therapeutics Plc | $395.55 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $171.84 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Davol INC. | $157.34 | 2023 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $147.25 | 2019-2021 | |
| Medacta USA, INC. | $108.25 | 2021 | |
| Ferring Pharmaceuticals INC. | $85.13 | 2019-2021 | |
| Eclipse Technology Solutions INC. | $68.91 | 2023 | |
| Pacira Cryotech Incorporated | $62.60 | 2019 | |
| Nextstep Arthropedix, LLC | $60.00 | 2019 | |
| Fidia Pharma USA INC. | $32.72 | 2024-2025 | Hymovis, Triluron |
| Wright Medical Technology, INC. | $22.48 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $21.11 | 2019 | |
| Vericel Corporation | $19.18 | 2024 | Maci |
| Sanofi-Aventis U.S. LLC | $15.87 | 2023 | |
| Convatec INC. | $15.63 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.96 | 2020 | |
| Pacira Therapeutics, INC. | $14.28 | 2019 | |
| Arthrosurface Incorporated | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dellose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.